Cognision360, the First Fully Integrated Digital Biomarker Platform for CNS Trials

• The challenges of implementing advanced neurobiomarkers in CNS trials
• Cognision360 digital biomarker platform, devices, data management, and analyses
• How Cognision360 streamlines the complex implementation of advanced neurobiomarkers
• Benefits to pharma sponsors, trial sites, and contract research organizations

Speakers:

K.C. Fadem

Chief Technology Officer

Cognision